VANCOUVER, British Columbia, Aug. 28, 2017 (GLOBE NEWSWIRE) -- TerraBioGen Technologies Inc., a developer of proprietary high-value agriculturally bioactive products, announces corn field trials from the 2016 growing season. The average yield increase of treated plot replicates was 14.9 percent over the untreated control. The trial was conducted by Ecologistics Research Services near London, Ontario, Canada. The commercial seed was provided through cooperation with a Tier 1 seed company and TerraBioGen’s product was applied as a standard thin film seed treatment.
“We are encouraged by these results which are consistent with the double digit percentage yield improvement achieved by our products over control plots in field corn trials conducted over the past 3 years.” said TerraBioGen’s CEO, Blair Heffelfinger.
About TerraBioGen
TerraBioGen Technologies Inc. is a developer of innovative, proprietary, high-value, environmentally sustainable bioproducts and biostimulants that improve crop health and yields, and increase abiotic and biotic stress tolerance in agricultural and horticultural crops. The Company is committed to research and development to continue to improve the effectiveness of its technologies, the quality of its products, and the creation of new product lines.
For more information, please contact:
| Blair Heffelfinger | Bob Nowell | |
| President & CEO | CFO | |
| TerraBioGen Technologies Inc. bheffelfinger@terrabiogen.com | TerraBioGen Technologies Inc. bnowell@terrabiogen.com | |
| (604) 444-1023 ext 316 | (604) 444-1023 ext 306 | |
| (604) 444-1043 fax | (604) 444-1043 fax | |
This news release contains certain statements that may be deemed “forward-looking” statements. Forward looking statements are statements that are not historical facts and are generally, but not always, identified by the words “expects”, “plans”, “anticipates”, “believes”, “intends”, “estimates”, “projects”, “potential” and similar expressions, or that events or conditions “will”, “would”, “may”, “could” or “should” occur. Although TerraBioGen believes the expectations expressed in such forward-looking statements are based on reasonable assumptions, such statements are not guarantees of future performance and actual results may differ materially from those in forward looking statements. Forward looking statements are based on the beliefs, estimates and opinions of TerraBioGen’s management on the date the statements are made. Except as required by law, TerraBioGen undertakes no obligation to update these forward-looking statements in the event that management’s beliefs, estimates or opinions, or other factors, should change.